DodoFinance Breaking News Made For You!
Dr. William Grady of Fred Hutch Cancer Center has led a groundbreaking study on a new blood test for colon cancer screenings, which could provide a more convenient and effective alternative to traditional methods. The study revealed that the blood test can detect 83% of people with colon cancer, making it just as reliable as at-home stool tests.
One of the main reasons why many individuals fail to follow through on at-home stool tests is due to the “ick factor,” which makes the blood test a more appealing option for those at average risk for colon cancer. Thanks to advances in DNA sequencing and artificial intelligence, this blood screening method has become a reality.
Dr. Grady is urging government regulators to review the study in order to secure insurance coverage for the blood test, as colon cancer is the second leading cause of cancer deaths in American adults and the risk is increasing. In fact, Dr. Grady predicts that colon cancer will become the most common cancer in individuals under the age of 50 within the next five years.
The introduction of this innovative blood test could potentially revolutionize the way colon cancer is detected and treated, ultimately saving countless lives. Patients and healthcare providers alike are hopeful that this new screening option will soon become widely available and accessible to all individuals at risk for colon cancer. Stay tuned for more updates on this groundbreaking development in cancer screening technology.
